Publication: Double check up of malignancy biopsy specimens for patient safety
Issued Date
2010-11-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-78649261818
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.93, No.11 (2010), 1310-1316
Suggested Citation
Pattana Sornmayura, Yingluck Visessiri, Mana Rochanawutanon, Vorachai Sirikulchayanonta, Rangsima Aroonroch, Wasana Kanoksil, Noppadol Larbcharoensub, Sansanee Wongwaisayawan, Juvady Leopairut, Panas Chalermsanyakorn, Suchin Worawichawong, Niramol Chanplakorn, Paisan Leelachaikul, Atcharaporn Pongtippan Double check up of malignancy biopsy specimens for patient safety. Journal of the Medical Association of Thailand. Vol.93, No.11 (2010), 1310-1316. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/29462
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Double check up of malignancy biopsy specimens for patient safety
Author(s)
Other Contributor(s)
Abstract
Background: The diagnostic of malignancy in biopsy specimens is very important because it guides to selected treatment option and prognostic prediction. However, biopsy specimens usually have small pieces leading to variations of the interpretation by anatomical pathologists. Objective: To detect and correct the errors or the significant discrepancies in the diagnosis of biopsy specimens before signout and to determine the frequency of anatomic pathology significant discrepancies. Design: The application of the mutually agreed work instructions (record) for the detection of errors or the significant discrepancies and their process of sign-out. The record of biopsy specimen that received a secondary check (1,959 cases, 2005-2007) was analyzed. Results: After a secondary check, 53 cases of non-malignancy for any reason by a second pathologist were included. However, when using our definition on significant discrepancies, only 37 cases were considered. Another seven cases with the opinions with malignancy that were of different cell types that do harm to the patients were added. Therefore, 44 cases (2.25%) had truly significant discrepancies. Conclusion: The truly significant discrepancy frequency was 2.25% during the process of pre-sign-out secondary check of malignancy of biopsy specimens. The project has been applied as a routine daily work. It can be an innovative safety program for patient in Thailand.